New study analyzes barriers to cancer research commercialization

October 30, 2013, University of Kentucky

A new study led by the University of Kentucky Markey Cancer Center Assistant Director for Research Nathan Vanderford cites a combination of factors that prevent academic-based cancer research faculty from ultimately commercializing their work.

According to the Association of University Technology Managers, academic institutions have been collectively generating more than $2 billion in commercialization income over the last several years. Despite this significant commercialization activity, studies have shown that academic institutions face challenges to commercializing their innovations. Identifying and adjusting for these challenges can further boost academic-based research commercialization, thus having significant benefits for universities and consumers.

Published in PLOS One, Vanderford's study utilized an electronic survey sent to faculty at the University of Kentucky with questions addressing general barriers inhibiting commercialization and whether mitigation of the barriers could potentially enhance faculty engagement in commercialization activities.

Through the survey, faculty cited a number of barriers to moving research products into the market, including the expense and time involved, the lack of infrastructure for the process, and the lack of industry partnerships.

Additionally, survey respondents noted that alleviating these factors as well as revising university policies/procedures, risk mitigation, more emphases on commercialization by academia research field, and increased information on how to commercialize could potentially increase commercialization activity. Further statistical analysis indicated that a significant increase in commercialization activity would likely only occur when multiple barriers were mitigated.

"This study suggests that the barriers inhibiting cancer at UK are, by in large, no different than the barriers that prevent commercialization at any academic institution," Vanderford said. "I believe we have to understand these challenges and devise ways to overcome them to avoid situations where important innovations sit dormant in universities. It would be a shame for a revolutionarily effective treatment to never make it to patients because the barriers to the process prevent it from moving outside the walls of academia."

Though the UK study was focused on a single population of researchers, Vanderford notes that his study fits into a much broader international discussion on what role universities should play in commercializing innovation that is derived from academic-based research. The dissenting argument is that universities should focus on the pursuit of general, basic knowledge versus being influenced by real or potential consumer-driven market demands.

Explore further: Organizational climate drives commercialization of scientific and engineering discoveries

More information: www.plosone.org/article/info%3 … journal.pone.0072268

Related Stories

Organizational climate drives commercialization of scientific and engineering discoveries

July 7, 2011
Research universities with an organizational climate that actively supports commercialization and encourages interdisciplinary collaboration among researchers are more likely to produce invention disclosures and patent applications, ...

Time for tech transfer law to change? U-M doctor looks at history of Bayh-Dole and says yes

August 29, 2013
The law that has helped medical discoveries make the leap from university labs to the marketplace for more than 30 years needs revising, in part to ensure the American people benefit from science their tax dollars have paid ...

Social service barriers delay care among women with abnormal cancer screening

October 25, 2013
A recent study performed by researchers at Boston Medical Center (BMC), Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and Tufts Medical Center found that women with multiple ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.